Senti Biosciences, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Senti Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2021 to Q1 2024.
  • Senti Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $0.000.
  • Senti Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $779K, a 99.3% decline from 2022.
  • Senti Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $119M, a 73.2% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 +$35K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$35K +$420K +92.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$455K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q2 2021 $232M Mar 1, 2021 Jun 30, 2021 10-Q/A 2021-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.